Cite
HARVARD Citation
Burnett, J. et al. (2015). MANP: a novel particulate guanylyl cyclase A receptor/cGMP activator for resistant hypertension: preliminary first in human clinical trial results. BMC pharmacology & toxicology. 16 (1), pp. 1-2. [Online].